Data suggest that over 70 per cent of people experience an episode of headache every month and 36 per cent suffer from it every week. It is this opportunity that healthcare company Sanofi India wants to tap into, through Combiflam Plus, an over-the-counter tablet for headaches. (The data was collected through an internal market research done last year, across a sample of 400 consumers.)

Combiflam Plus is available in a pack of four tablets priced at Rs 9.50. It has initially been launched in Tamil Nadu, Maharashtra, Uttar Pradesh, Haryana, West Bengal and Punjab. The market for headache tablets in the country is estimated at Rs 233 crore. Sanofi wants to garner a market share of 4-5 per cent and Rs 10 crore revenues in three years, said Anindya Chowdhury, Senior Director – Consumer Healthcare, Sanofi India. The company already sells the Combiflam brand of pain-killers.

Related Topics